Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Prokidney Corp (PROK)

Prokidney Corp (PROK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Prokidney Corp 2000 FRONTIS PLAZA BLVD SUITE 250 WINSTON-SALEM NC 27103 USA

www.prokidney.com Employees: 204 P: 336-999-7019

Sector:

Medical

Description:

ProKidney LP is a late clinical-stage cellular therapeutics company focused on CKD. The company's lead product candidate includes REACT(TM) is a first-of-its-kind, patented disease-modifying autologous cellular therapy. ProKidney LP, formerly known as Suvretta Holdings Corp. III, is based in WINSTON-SALEM, N,C.

Key Statistics

Overview:

Market Capitalization, $K 655,818
Enterprise Value, $K 1,953,288
Shares Outstanding, K 300,834
Float, K 176,018
% Float 58.51%
Short Interest, K 13,813
Short Float 4.59%
Days to Cover 12.16
Short Volume Ratio 0.70
% of Insider Shareholders 41.49%
% of Institutional Shareholders 51.59%
Annual Net Income, $ -61,190 K
Last Quarter Sales, $ 220 K
Last Quarter Net Income, $ -16,470 K
EBIT, $ -171,290 K
EBITDA, $ -165,860 K
3-Year Return -76.98%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.12 on 11/10/25
Next Earnings Date 03/16/26
Earnings Per Share ttm -0.55
EPS Growth vs. Prev Qtr 7.69%
EPS Growth vs. Prev Year 14.29%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PROK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -18.09%
Profit Margin % -76,487.50%
Debt/Equity 0.00
Price/Sales 383.09
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -3.41
Interest Coverage -16,392.00
60-Month Beta 1.79
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar